Skip to main content
. 2022 Jan 20;22:85. doi: 10.1186/s12885-021-09160-1

Fig. 2.

Fig. 2

Relative contribution of de novo mutational signatures in plasma and tumour samples. P0 – denotes plasma samples and T0 – denotes tumour samples